Corporate Banner
Satellite Banner
Technology Networks Header
Friday, November 28, 2014
Technology Networks
 
Register | Sign in
Home Page>Application Notes

  Application Notes

Efficient Delivery of siRNA in Human Renal Cell Carcinoma Cell Line Us

Genovis
More information
FabRICATOR® - perfect F(ab?)2 fragments in minutes

Genovis
More information
First siRNA Library Screening in Hard-to-Transfect HUVEC and Jurkat Ce

Amaxa GMBH
More information
Knockdown of BACE-1, an Alzheimer’s Disease Drug Target, with NIMT®FeO

Genovis
More information
Measurement of Proteasome Inhibition in Live Cells in Molecular Device

Molecular Devices
More information
NIMT®FeOfection|PURPLE in siRNA Delivery into HEK293 Cells

Genovis
More information
Nucleofection® Enables Luciferase Reporter Assays in Primary Cells and

Amaxa GMBH
More information
Optimized cell culture

Tecan Group Ltd.
More information
RNAi-mediated CD2 suppression in primary human T cells

Amaxa GMBH
More information
<< 1 2 3 >>
showing results 10 to 18 of 22
Scientific News
Two Studies Identify A Detectable, Pre-Cancerous State In The Blood
Findings pave way for new lines of cancer research focused on detection and prevention.
New Device Could Make Large Biological Circuits Practical
Innovation from MIT could allow many biological components to be connected to produce predictable effects.
Precisely Off The Mark
Possible cause discovered for failure of targeted liver cancer therapies.
Novel Cancer Vaccine Approach for Brain Tumors
Researchers unravel the mechanisms behind a novel cancer vaccine for brain tumors, paving the way for further development.
New Test Developed at Dana-Farber/Brigham and Women's Cancer Center
Rapid Heme Panel - A high-tech genetic test that speeds treatment decisions for blood cancer patients.
Researchers Silence Leading Cancer-Causing Gene
A novel siRNA-based molecule successfully targets KRAS, a well-studied but hard to halt protein important for cancer development and metastasis.
Tumor Suppressor Also Inhibits Key Property Of Stem Cells
The retinoblastoma protein inhibits cancer by controlling cell division. Now, researchers have shown that it also binds to and inhibits genes necessary for pluripotency.
Almac Announces Launch of CLIA Validated Next Generation Sequencing Assay
P53 considered important biomarker for cancer drug discovery.
Next-Gen Melanoma Drug Excels in Lab Tests
Anti-cancer activity was reported in 10 out of 11 patient tumor samples grown in mice and treated with the experimental drug TAK-733.
Study Identifying Cell of Origin for Large, Disfiguring Nerve Tumors
Lays groundwork for development of new therapies.
SELECTBIO
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv